Metal complexes in cancer therapy–an update from drug design perspective

U Ndagi, N Mhlongo, ME Soliman - Drug design, development and …, 2017 - Taylor & Francis
In the past, metal-based compounds were widely used in the treatment of disease
conditions, but the lack of clear distinction between the therapeutic and toxic doses was a …

The involvement of the oxidative stress status in cancer pathology: a double view on the role of the antioxidants

KF Zahra, R Lefter, A Ali, EC Abdellah… - Oxidative Medicine …, 2021 - Wiley Online Library
Oxygen‐free radicals, reactive oxygen species (ROS) or reactive nitrogen species (RNS),
are known by their “double‐sided” nature in biological systems. The beneficial effects of …

Recent development of copper (II) complexes of polypyridyl ligands in chemotherapy and photodynamic therapy

J Rani J, S Roy - ChemMedChem, 2023 - Wiley Online Library
Cancer is a deadly disease associated with abnormal cell growth and invasion to various
parts of the body. Many drugs such as cisplatin and carboplatin have been used for the …

Synthesis, DNA binding and antibacterial activity of metal (II) complexes of a benzimidazole Schiff base

K Mahmood, W Hashmi, H Ismail, B Mirza, B Twamley… - Polyhedron, 2019 - Elsevier
Abstract The benzimidazole derivative (E)-2-((4-(1H-benzo [d] imidazol-2-yl) phenylimino)
methyl)-4-bromo phenol and the corresponding Zn (II), Ni (II), Cu (II), and Pd (II) complexes …

[HTML][HTML] Copper homeostasis and copper-induced cell death: novel targeting for intervention in the pathogenesis of vascular aging

Z Chen, Y Li, X Liu - Biomedicine & Pharmacotherapy, 2023 - Elsevier
Copper-induced cell death, also known as cuproptosis, is distinct from other types of cell
death such as apoptosis, necrosis, and ferroptosis. It can trigger the accumulation of lethal …

Redox-implications associated with the formation of complexes between copper ions and reduced or oxidized glutathione

ME Aliaga, C López-Alarcón, R Bridi… - Journal of inorganic …, 2016 - Elsevier
Binding of copper by reduced glutathione (GSH) is generally seen as a mechanism to lower,
if not abolish, the otherwise high electrophilicity and redox activity of its free ions. In recent …

Metal complexes of benzimidazole derived sulfonamide: Synthesis, molecular structures and antimicrobial activity

A Ashraf, WA Siddiqui, J Akbar, G Mustafa… - Inorganica Chimica …, 2016 - Elsevier
Benzimidazole and sulfonamide moieties are found in a number of pharmaceutically active
molecules. By incorporating the sulfonamide pharmacophore into the benzimidazole …

Synthesis, characterization, molecular docking and antimicrobial activity of copper (II) complexes of metronidazole and 1, 10 phenanthroline

AT Gordon, OO Abosede, S Ntsimango… - Inorganica Chimica …, 2020 - Elsevier
Three new compounds containing mono-and dinuclear Cu (II) complexes,[Cu (Met) 2 Cl 2] 2,
Cu (H 2 O)(Met) 2 Cl] 2 and [Cu (H 2 O)(phen) 2] NO 3 (Met= metronidazole; Phen= 1, 10 …

Emerging Trends in Metal‐based Anticancer Agents: Drug Design to Clinical Trials and their Mechanism of Action

A Temesgen, HC Ananda Murthy, AZ Enyew… - …, 2023 - Wiley Online Library
Metal‐based therapeutic strategies have been effectively used to treat a number of diseases
since the ancient period. However, the issue that emerged at this time was the indistinct …

An insight into the cytotoxic, antimicrobial, antioxidant, and biocontrol perspective of novel Iron (III) complexes of substituted benzimidazoles: Inhibition kinetics and …

B Roopashree, B Mahesh, R Ramu… - Journal of …, 2024 - Taylor & Francis
Abstract Mononuclear complexes [FeCl3L2 (OH2)](L= L1, L2) were designed and
synthesized by combining FeCl3 with 2-(3′-Aminophenylbenzimidazole)(L1) and 2-[(3′-N …